C-type natriuretic peptide forms in adult hyperthyroidism: correlation with thyroid hormones and markers of bone

Belinda J Schouten1, Timothy C Prickett, Penelope J Hunt

  • 1Department of Endocrinology, Christchurch Hospital, Christchurch, New Zealand.

Clinical Endocrinology
|November 23, 2011
PubMed

Insights

Thyroid hormones (TH) influence C-type natriuretic peptide (CNP) levels in adults, similar to children. Restoring euthyroidism in hyperthyroid adults affects CNP and bone turnover markers, suggesting CNP

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Cardiovascular Peptides

Background:

  • Plasma C-type natriuretic peptide (CNP) levels correlate with linear growth in children.
  • In hyperthyroid children, CNP and thyroid hormones (TH) decrease in parallel as euthyroidism is restored.
  • The impact of TH on CNP after skeletal maturity is not well understood.

Purpose of the Study:

  • To investigate the effect of normalizing thyroid hormone levels on plasma CNP forms.
  • To assess changes in bone turnover markers (BTMs) in hyperthyroid adults during treatment.
  • To determine the relationship between CNP, TH, and BTMs in adults.

Main Methods:

  • Prospective observational study of 20 adults with acquired hyperthyroidism.
  • Measurement of plasma C-type natriuretic peptide (CNP), amino-terminal propeptide of CNP (NTproCNP), thyroid hormones (TH), and bone turnover markers (BTMs).
  • Serial measurements were taken before and during 6 months of carbimazole treatment, with correlation analyses performed.

Main Results:

  • Plasma CNP and NTproCNP levels significantly correlated with TH at baseline.
  • Decreases in CNP forms paralleled the reduction in TH during treatment.
  • Significant associations were observed between CNP forms and bone resorption marker CTx.

Conclusions:

  • C-type natriuretic peptide (CNP) production is responsive to thyroid hormones (TH) in adult tissues beyond cartilage.
  • The temporal relationship between CNP and bone resorption markers suggests a role for CNP in adult bone remodeling.
  • Thyroid hormone status impacts both CNP and bone turnover in adults.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...